Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing

Abstract

Homologous recombination proficiency in patients with breast cancer despite germline PALB2/RAD51C pathogenic variants.